Lupin gets USFDA nod for primary biliary cholangitis drug Obeticholic Acid Ruchika Sharma24 March 2023 2:00 PM ISTMumbai: Global pharma major, Lupin Limited, has announced that the company has received tentative approval from the United States Food and Drug...
Lupin gets USFDA approval for generic equivalent of Rexulti Tablets Ruchika Sharma22 March 2023 11:45 AM ISTThis product would be manufactured at Lupin's Pithampur facility in India.
USFDA nod to Caplin Steriles Rocuronium Bromide Injection Ruchika Sharma21 March 2023 12:15 PM ISTMumbai: Pharma major Lupin Limited has announced that its alliance partner Caplin Steriles Limited has received final approval from the United States...
Lupin Digital Health declares results of digital therapeutics study with acute coronary syndrome patients Ruchika Sharma19 March 2023 10:00 AM ISTThe study results indicate that digital therapeutics programs will have a crucial role in patient care across the cardiology continuum, powered by...
Lupin gets zero USFDA observations for Bioresearch Centre in Pune Ruchika Sharma14 March 2023 11:07 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed an inspection of...
USFDA issues zero observation to Lupin Vizag facility Ruchika Sharma11 March 2023 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a Pre-Approval...
Lupin Diagnostics unveils new Regional Reference Laboratory in Hyderabad Ruchika Sharma1 March 2023 5:15 PM ISTHyderabad: Global pharma major Lupin Limited announced today the launch of its new Regional Reference Laboratory in Hyderabad, Telangana."This...
Lupin unveils schizophrenia drug Lurasidone Hydrochloride in US Ruchika Sharma23 Feb 2023 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120...
Lupin gets USFDA EIR for Nagpur facility Ruchika Sharma17 Feb 2023 11:36 AM ISTMumbai: Global pharma major Lupin Limited today announced that the company has received the Establishment Inspection Report (EIR) from the United...
Lupin unveils Neuro-rehabilitation center in Mumbai Ruchika Sharma15 Feb 2023 1:15 PM ISTMumbai: Pharma major, Lupin Limited, has announced the launch of a world-class Neuro-rehabilitation center, Atharv Ability in Bandra Kurla...
Lupin reports 72 percent decline in consolidated net profit at Rs 153 crore for Q3 Ruchika Sharma11 Feb 2023 9:00 AM ISTNew Delhi: Drug maker Lupin has reported 72 percent decline in consolidated net profit at Rs 153 crore for the third quarter ended December 31,...
USFDA nod to Lupin Glycopyrrolate Injection Ruchika Sharma9 Feb 2023 12:05 PM ISTMumbai: Global pharma major Lupin Limited today announced that the company has received approval from the United States Food and Drug Administration...
